Liliya Eugenevna Ziganshina

Prof. Liliya Eugenevna Ziganshina

Cochrane Russia
+2
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1997 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
BKB F King
B F King
SWS S Wildman
S S Wildman
Liliya Eugenevna ZiganshinaLiliya Eugenevna Ziganshina
Liliya Eugenevna Ziganshina
JPJ Pintor
J Pintor
GBG Burnstock
G Burnstock
Under voltage‐clamp conditions, the activity of agonists and antagonists at a recombinant P2X2 receptor expressed in Xenopus oocytes was examined at different levels of extracellular pH (pHe). In normal Ringer (Mg2+ ions absent), the amplitude of submaximal inward currents to ATP was increased by progressively lowering pHe (8.0–5.5). ATP‐responses reached a maximum at pH 6.5 with a 5 fold increase in ATP‐affinity; the apparent pKa was 7.05±0.05. Receptor affinity for ATP was lowered when extracellular Ca2+ ions were replaced with equimolar Mg2+ ions. However, the amplitude of the ATP‐responses was still enhanced under acidic conditions, reaching maximal activity at pH 6.5 with a 5 fold increase in ATP‐affinity; the apparent pKa was 7.35±0.05. ATP species present in the superfusate (for the above ionic conditions and pH levels) were calculated to determine the forms of ATP which activate P2X2 receptors: possible candidates include HATP, CaHATP and MgHATP. However, levels of these protonated species increase below pH 6.5, suggesting that receptor protonation rather than agonist protonation is more important. The potency order for agonists of P2X2 receptors was: ATP>2‐MeS‐ATPATPγS> ATPαS>>CTPBzATP, while other nucleotides were inactive. EC50 and nH values for full agonists were determined at pH 7.4 and re‐examined at pH 6.5. Extracellular acidification increased the affinity by approximately 5 fold for full agonists (ATP, 2‐MeSATP, ATPγS and ATPαS), without altering the potency order. The potency order for antagonists at P2X2 receptors was: Reactive blue‐2>trinitrophenol‐ATPPalatine fast blackCoomassie brilliant bluePPADS>suramin (at pH 7.4). IC50 values and slopes of the inhibition curves were re‐examined at different pH levels. Only blockade by suramin was affected significantly by extracellular acidification (IC50 values: 10.4±2 μM, at pH 7.4; 78±5 nM, at pH 6.5; 30±6 nM, at pH 5.5). In summary, a lowered pHe enhanced the activity of all agonists at P2X2 receptors but, with the exception of suramin, not antagonists. Since a lowered pHe is also known to enhance agonist activity at P2X receptors on sensory neurones containing P2X2 transcripts, the sensitization by metabolic acidosis of native P2X receptors containing P2X2 subunits may have a significant effect on purinergic cell‐to‐cell signalling.

1 April 1996 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
BKBrian F. King
Brian F. King
Liliya Eugenevna ZiganshinaLiliya Eugenevna Ziganshina
Liliya Eugenevna Ziganshina
JPJesus Pintor
Jesus Pintor
GBGeoffrey Burnstock
Geoffrey Burnstock
A full pharmacological characterization was carried out on a recombinant ATP-gated ion channel (P2times2 purinoceptor) expressed in Xenopus oocytes. This slowly-desensitizing neuronal P2times2 purinoceptor, activated by ATP (EC50 = 4.6 ± 1 μm at pH 7.4; n 4), showed the agonist potency order: ATP ≥ 2- MeSATP = ATPγS ≥ ATPαS < < Bz-ATP. The receptor affinity for ATP was enhanced 5–10 fold by acidifying the bathing solution (to pH 6.5) but was diminished 4–5 fold in an alkaline solution (pH 8.0). The maximum activity of P2times2 purinoceptors and the activity order of a series of nucleotides were unaltered by changing extracellular pH. Interestingly, ATP sensitivity at a recombinant P2Y1, purinoceptor remained unaltered with changing extracellular pH. These results indicate that acidotic conditions in the synaptic cleft could strengthen purinergic transmission at neuronal P2times2 purinoceptors.

1 November 2021 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
Eduard BaladiaEduard Baladia
Eduard Baladia
MEM. Ellen
M. Ellen
IKI. Klerings
I. Klerings
RSRaluca Sfetcu
Raluca Sfetcu
NRN. Riva
N. Riva
GGG. Gartlehner
G. Gartlehner
We aimed to map the resource use during systematic review (SR) production and reasons why steps of the SR production are resource intensive to discover where the largest gain in improving efficiency might be possible. We conducted a scoping review. An information specialist searched multiple databases (e.g., Ovid MEDLINE, Scopus) and implemented citation-based and grey literature searching. We employed dual and independent screenings of records at the title/abstract and full-text levels and data extraction. We included 34 studies. Thirty-two reported on the resource use-mostly time; four described reasons why steps of the review process are resource intensive. Study selection, data extraction, and critical appraisal seem to be very resource intensive, while protocol development, literature search, or study retrieval take less time. Project management and administration required a large proportion of SR production time. Lack of experience, domain knowledge, use of collaborative and SR-tailored software, and good communication and management can be reasons why SR steps are resource intensive. Resource use during SR production varies widely. Areas with the largest resource use are administration and project management, study selection, data extraction, and critical appraisal of studies.

7 August 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
OTOlga V. Tsepaeva
Olga V. Tsepaeva
ANAndrey V. Nemtarev
Andrey V. Nemtarev
TATimur Abdullin
Timur Abdullin
LGLeysan R. Grigor’eva
Leysan R. Grigor’eva
EKElena V. Kuznetsova
Elena V. Kuznetsova
VMVladimir F. Mironov
Vladimir F. Mironov

1 January 1995 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
AZAyrat U. Ziganshin
Ayrat U. Ziganshin
Liliya Eugenevna ZiganshinaLiliya Eugenevna Ziganshina
Liliya Eugenevna Ziganshina
BKBrian F. King
Brian F. King
GBGeoffrey Burnstock
Geoffrey Burnstock

1 April 1996 in Biochemical Pharmacology
Verified
Journal Article
Closed access
AZAyrat U. Ziganshin
Ayrat U. Ziganshin
Liliya Eugenevna ZiganshinaLiliya Eugenevna Ziganshina
Liliya Eugenevna Ziganshina
BKBrian F. King
Brian F. King
JPJesus Pintor
Jesus Pintor
GBGeoffrey Burnstock
Geoffrey Burnstock